Hazra, M. A Rational Pharmacotherapeutic Study of Comparative Safety Among Topical Anti-Acne 1% Nadifloxacin Monotherapy, 0.1% Adapalene Monotherapy, 0.025% Tretinoin Monotherapy, 1% Nadifloxacin and 0.1% Adapalene Combination Therapy and 1% Nadifloxacin and 0.025% Tretinoin Combination Therapy, in Mild to Moderate Acne Vulgaris, in Tertiary Care Hospitals. Int J Basic Clin Pharmacol 2019, 8, 1959-1965.